Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2810498 | Trends in Endocrinology & Metabolism | 2011 | 7 Pages |
Impaired function of pancreatic β-cells is one of the hallmarks of type 2 diabetes. β-cell function is regulated by the activity of many hormones and neurotransmitters, which bind to specific cell surface receptors. The M3 muscarinic acetylcholine receptor (M3R) belongs to the superfamily of G protein-coupled receptors and, following ligand dependent activation, selectively activates G proteins of the Gq/11 family. Recent studies with M3R mutant mice strongly suggest that β-cell M3Rs play a central role in promoting insulin release and maintaining correct glucose homeostasis. In this review, we highlight recent studies indicating that β-cell M3Rs and components of downstream signaling pathways might represent promising new targets for the treatment of type 2 diabetes.